Accelerate Early Phase Development with Precision

Discover Precision's end-to-end manufacturing advisory, from preclinical to commercial scale. Specializing in advanced therapy medicinal products, we provide strategic planning, process optimization, facility design, and regulatory guidance. Our Manufacturing Solutions team at Precision for Medicine, formerly known as Project Farma, ensures your therapy's scalable production and accelerated market entry. Learn how our comprehensive services can navigate your product through complex manufacturing challenges to successful launch.

Enhance your access to capital with Stern IR, a Precision company, renowned for expert investor relations for companies at all stages of development. With 25 years’ experience connecting novel science and medicine to the financial resources that enable novel therapeutic, we heighten your company’s visibility among investors and analysts and clearly communicate your medical innovations to this audience. Whether you're a preclinical startup or a late stage clinical trailblazer, our tailored IR approach is designed to secure the resources necessary for your clinical journey's success. 

Craft an impactful value proposition early in your therapy's journey with Precision's HEOR and market access experts.  We illuminate the path to market by aligning HEOR and access insights and strategy with your clinical development and investment plans. By highlighting unmet need, competitive landscape analyses, and stakeholder perspectives, we position your innovation for success. Our tailored solutions, including early economic modeling, ensure your therapy not only meets clinical goals but also showcases its real-world impact, enhancing appeal to investors and payers alike.